Skip to content

Viking Therapeutics VKTX Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Amgen logo
AmgenAMGN
$4.11B+26.2%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$64.96M+179%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$22.36M+36.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$11.84M-46.1%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$205.5M+13.2%

Other financials

Income statement

See full
Revenue-
Operating income-$164.1M-196%
Net income-$158.3M-247%
EPS (diluted)-$1.37-234%

Balance sheet

See full
Cash & equivalents$118.1M+211%
Total debt$137.0K-87.8%
Total equity$501.9M-40.7%
Total assets$608.2M-29.8%

Cash flow

See full
Operating cash flow-$114.0M-118%

Valuation

See full
Market cap$4.04B+38.7%

Returns & leverage

See full
Return on equity-70%-94.5pp
Debt / equity0.0×
Current ratio5.7×-38.5×

Where this comes from

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viking Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viking Therapeutics's prepaid & other current?
Viking Therapeutics (VKTX) reported prepaid & other current of $1.22M in Q1 2026.
How has Viking Therapeutics's prepaid & other current changed year-over-year?
Viking Therapeutics's prepaid & other current increased by 41.5% year-over-year, from $865K to $1.22M.
What is the long-term trend for Viking Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Viking Therapeutics's prepaid & other current has grown at a 32.5% compound annual growth rate (CAGR), from $442K to $1.81M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.